TY  - JOUR
AU  - Djouder, Nabil
PY  - 2015
DO  - 10.1080/23723556.2014.1001199
SN  - 2372-3556
UR  - http://hdl.handle.net/20.500.12105/17548
AB  - Hepatocellular carcinoma (HCC) is the third leading cause of cancer death worldwide yet has limited therapeutic options. We recently demonstrated that inhibition of de novo nicotinamide adenine dinucleotide (NAD(+)) synthesis is responsible for DNA...
LA  - eng
PB  - Taylor & Francis
TI  - Boosting NAD(+) for the prevention and treatment of liver cancer.
TY  - journal article
ER  -